Cevian Capital Sold Its Whole Stake in Aviva
By Elena Vardon
Cevian Capital has exited its whole position in Aviva, the Stockholm-based financial investor told Dow Jones Newswires on Thursday.
"Over the past few years, Aviva has transformed from a poorly performing conglomerate to a focused and well-performing insurance company," Niko Pakalen, partner at Cevian Capital, said in a statement.
Pakalen said that the British insurer has "produced strong shareholder returns, including substantial distributions of excess capital" and that the company is "now well positioned for continued success, which isn't reflected in today's share price."
Activist investor Cevian had a 5.01% stake in Aviva as of Dec. 31 and had reduced it to under 5% at March 3, according to Aviva's 2022 annual report.
A spokesperson for Aviva confirmed to Dow Jones Newswires that Cevian informed it on Thursday that it sold its stake.
Write to Elena Vardon at elena.vardon@wsj.com
(END) Dow Jones Newswires
May 25, 2023 11:06 ET (15:06 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s Happening In the Markets This Week
-
How Anti-Obesity Drugs Are Innovating the Healthcare Market
-
Why Immigration Has Boosted Job Gains and the Economy
-
What to Invest in During High Inflation
-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
8 Stock Picks in the Apparel Industry
-
Baidu Earnings: Advertising Weakness Offset by Continued Growth In Cloud Business
-
Going Into Earnings, Is Target Stock a Buy, a Sell, or Fairly Valued?
-
Walmart Earnings: Low Prices and Strong Digital Presence Drive Market Share Gains
-
After Earnings and a Big Selloff, Is Shopify Stock a Buy, a Sell, or Fairly Valued?
-
Cisco Earnings: Positive Guidance and Splunk Inclusion Align With Our Long-Term Thesis
-
3 Warren Buffett Stocks to Buy After Berkshire Hathaway’s Just-Released 13F Filing
-
Going Into Earnings, Is Nvidia Stock a Buy, a Sell, or Fairly Valued?